Herbalife (NYSE: HLF) director Sophie L’Helias reports open-market stock purchases

Rhea-AI Filing Summary

Herbalife Ltd. director reports open-market stock purchases

A director of Herbalife Ltd. (HLF), Sophie L'Helias, reported buying common stock in two open-market transactions. On November 26, 2025, she purchased 400 shares of Herbalife common stock at a price of $13.22 per share. On December 1, 2025, she bought an additional 800 shares at $12.70 per share. After these transactions, she directly beneficially owns 66,803 shares of Herbalife common stock. The filing is reported on a Form 4 for a single reporting person.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

L'Helias Sophie

(Last) (First) (Middle)

800 WEST OLYMPIC BLVD.

SUITE 406

(Street)

LOS ANGELES CA 90015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HERBALIFE LTD. [ HLF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/26/2025		P		400	A	$13.22	66,003	D
Common Stock	12/01/2025		P		800	A	$12.7	66,803	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Alaaeddine Sahibi, as Attorney-In- Fact for Sophie L'Helias	12/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Herbalife (HLF) report in this Form 4?

The Form 4 reports that director Sophie L'Helias purchased Herbalife common stock in the open market on two dates, adding a total of 1,200 shares to her holdings.

How many Herbalife (HLF) shares did the director buy and at what prices?

On November 26, 2025, the director bought 400 shares at $13.22 per share, and on December 1, 2025, she bought 800 shares at $12.70 per share.

What is the director’s total Herbalife (HLF) share ownership after these trades?

Following the reported purchases, director Sophie L'Helias directly beneficially owns 66,803 shares of Herbalife common stock.

What is the reporting person’s relationship to Herbalife (HLF)?

The reporting person, Sophie L'Helias, is identified as a director of Herbalife Ltd. on the Form 4.

Were there any derivative securities reported for Herbalife (HLF) in this Form 4?

The section for derivative securities (such as options or warrants) shows headings but no derivative transactions or holdings reported for this filing.

Who signed the Form 4 for the Herbalife (HLF) director?

The Form 4 was signed by /s/ Alaaeddine Sahibi acting as Attorney-In-Fact for Sophie L'Helias, dated December 1, 2025.